Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.
about
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive ReviewHepatic osteodystrophyClinical biomarkers and pathogenic-related cytokines in rheumatoid arthritisRib fractures and death from deletion of osteoblast βcatenin in adult mice is rescued by corticosteroidsAnti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone lossRANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesLoss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in miceMyeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo.Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiationAccelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritisSH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis modelCytokine-mediated bone destruction in rheumatoid arthritis.Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis.TNFalpha mediates the skeletal effects of thyroid-stimulating hormoneEarly metacarpal bone mineral density loss using digital x-ray radiogrammetry and 3-tesla wrist MRI in established rheumatoid arthritis: a longitudinal one-year observational study.Anthocyanin Extracted from Black Soybean Seed Coats Prevents Autoimmune Arthritis by Suppressing the Development of Th17 Cells and Synthesis of Proinflammatory Cytokines by Such Cells, via Inhibition of NF-κB.Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts.Protective and destructive immunity in the periodontium: Part 2--T-cell-mediated immunity in the periodontium.Temporal differential effects of proinflammatory cytokines on osteoclastogenesisReceptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Osteoclasts-Key Players in Skeletal Health and Disease.Polymethylmethacrylate particles stimulate bone resorption of mature osteoclasts in vitro.Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast functionNF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.Disease Activity and Bone Mineral Density of MCP Joints in Patients with Rheumatoid and Psoriatic Arthritis: Is There a Correlation?-A Study in Patients Treated with Methotrexate and an Anti-TNF α Agent.The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.The genomic landscape of human immune-mediated diseases.The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes.PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial.RANKL expression in periodontal disease: where does RANKL come from?STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis.Downregulation of miR-106b attenuates inflammatory responses and joint damage in collagen-induced arthritis.Mast cell degranulation in human periodontitis.Tumor Necrosis Factor Alpha Promotes Osteoclast Formation Via PI3K/Akt Pathway-Mediated Blimp1 Expression Upregulation.Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
P2860
Q24812326-2CD64A81-7FEB-405F-B4F7-2BEF413ACFC0Q26774874-20D72E05-ED80-416A-9A21-F0143C453498Q27004571-ECD7A35E-5E6F-4D98-A4B7-90F55A06653BQ27022559-7C6CE2E6-CCA3-4B6E-BAE4-C94F34AE2885Q27316361-1BF1C415-CD78-44D2-8ADF-667872A23760Q28245637-5310222D-8A59-4434-A195-AD8C956286EBQ28570898-A5F08093-941D-494B-9EB2-E62443366C88Q30009262-FE05A0F3-AF7D-42E8-8B85-09BC8312859CQ30278787-753D5593-9851-4C55-B7C1-BC1FA3C7D6CFQ33788192-1239D1E8-F296-4387-857A-DD8E0E38C795Q33946711-8CE24A63-C89C-4E16-97CF-87095D9450E6Q34027510-BCEED41C-7DD3-4D38-A5EC-23C37F0EFACEQ34075583-ADA338E5-2172-434F-836A-765C0A4A70EDQ34252489-7D8A2F34-7F0A-47DB-AA00-EA1EEE4926A5Q34468474-510EF1A1-6988-483C-B48B-2595E30E787CQ35036487-986C6F82-9461-4F2E-8A65-263692EF0F9BQ35138304-D9C35FE3-520B-414C-952F-BFF8BED832E9Q36257623-E0E28680-C359-4207-BC86-6DC63C7E1CF8Q36315765-FD2DBBC8-B8BC-46D1-A49E-A04F7481019AQ36404753-679388AA-6AE5-4464-88D1-462AE4D0C8F9Q36753683-3228DB62-97B8-48A9-AA62-B5D2158AB1CCQ36860987-D3D7786F-5993-4A9B-B846-522ED9CB57EEQ37036135-85CC6593-085A-495D-BF06-DF0B6C98AD08Q37142926-73DA2F02-F0F6-4D02-BE1F-5E2E3D66FC24Q37238209-F1264C2F-E850-4143-99FD-1CEB843868B5Q37363042-07AFDC05-2B7B-4BF7-B52A-742F9081BBE6Q37411976-4A592B12-8598-4A4D-99B5-582C726A69C5Q38207758-63549D68-71A9-4BA8-A855-A8B7D50DB061Q38569875-CA2D86A4-D029-4296-A9C4-2C5B71BE6B8FQ38669228-F265691A-CC26-4871-98C0-87422E7DBC90Q38744013-168BF24C-7976-4C35-88B7-81CF15D72B11Q39271170-C66A33F7-3D5D-4743-A5F8-ED40B9A8E099Q39998140-A244262B-F61B-4A99-829C-DFD584E400FFQ42409559-20124664-2F95-4854-96A4-AB318D71D9FEQ44689404-202C3DA4-45F9-4CF5-A026-8CA0EABC87CEQ47731229-EE26119C-4110-4BCB-B73D-016E83B585E7Q50248557-169741AD-71BB-406B-9ABB-26D3D712182AQ51582679-4D843132-C65F-4A10-BDA5-811642920691Q54292098-C6E090BC-E8E9-49A8-9022-1898279621E1
P2860
Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Joint erosion in rheumatoid ar ...... (RANKL) regulate osteoclasts.
@en
Joint erosion in rheumatoid ar ...... (RANKL) regulate osteoclasts.
@nl
type
label
Joint erosion in rheumatoid ar ...... (RANKL) regulate osteoclasts.
@en
Joint erosion in rheumatoid ar ...... (RANKL) regulate osteoclasts.
@nl
prefLabel
Joint erosion in rheumatoid ar ...... (RANKL) regulate osteoclasts.
@en
Joint erosion in rheumatoid ar ...... (RANKL) regulate osteoclasts.
@nl
P2093
P2860
P356
P1476
Joint erosion in rheumatoid ar ...... (RANKL) regulate osteoclasts.
@en
P2093
Compston JE
O' Gradaigh D
P2860
P304
P356
10.1136/ARD.2003.008458
P407
P577
2004-04-01T00:00:00Z